NCT06952842: Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 18 planned
- Started
- 4 Aug 2025
- Primary completion
- 18 Jun 2030
- Arms
- Single arm
- Results
- None posted
- 1 May 2025: Trial registered
- 4 Aug 2025: Trial started